<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1003756-Greenberg1">
 <label>61</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Greenberg</surname>
   <given-names>RN</given-names>
  </name>, 
  <name>
   <surname>Overton</surname>
   <given-names>ET</given-names>
  </name>, 
  <name>
   <surname>Haas</surname>
   <given-names>DW</given-names>
  </name>, 
  <name>
   <surname>Frank</surname>
   <given-names>I</given-names>
  </name>, 
  <name>
   <surname>Goldman</surname>
   <given-names>M</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2013</year>) 
  <article-title>Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects</article-title>. 
  <source>J Infect Dis</source>
  <volume>207</volume>: 
  <fpage>749</fpage>â€“
  <lpage>758</lpage>.
  <pub-id pub-id-type="pmid">23225902</pub-id>
 </mixed-citation>
</ref>
